FIND A PROTON CENTER
National Association for Proton Therapy National Association for Proton Therapy National Association for Proton Therapy National Association for Proton Therapy
  • ABOUT
    • About NAPT
    • Our Advocacy
    • Leadership
    • Awards
    • Corporate Partners
    • Join NAPT
  • PROTON THERAPY
    • History
    • FAQ
    • Pediatric Proton Therapy
  • FOR PATIENTS
    • Find A Proton Center
    • Patient Stories
    • Clinical Trials
    • Resource Center
  • FOR PROVIDERS
    • Clinical Research
    • Clinical Trials
  • EVENTS
  • NEWS
    • NAPT News
    • Proton Therapy In The News
National Association for Proton Therapy National Association for Proton Therapy
  • ABOUT
    • About NAPT
    • Our Advocacy
    • Leadership
    • Awards
    • Corporate Partners
    • Join NAPT
  • PROTON THERAPY
    • History
    • FAQ
    • Pediatric Proton Therapy
  • FOR PATIENTS
    • Find A Proton Center
    • Patient Stories
    • Clinical Trials
    • Resource Center
  • FOR PROVIDERS
    • Clinical Research
    • Clinical Trials
  • EVENTS
  • NEWS
    • NAPT News
    • Proton Therapy In The News
Mar 07

NAPT awards Jay Loeffler, MD the 2022 Lifetime Achievement Award

  • March 7, 2022

NATIONAL ASSOCIATION FOR PROTON THERAPY HONORS JAY LOEFFLER, MD AS THE 2022 LIFETIME ACHIEVEMENT AWARD RECIPIENT

Contact: JJ Vitale, NAPT Director of Communication ● jj@proton-therapy.org ● 202.919.4536

March 7, 2022 – In recognition of his pioneering work in the field of proton therapy, Dr. Jay Loeffler, physician, and clinical researcher, has been awarded the National Association for Proton Therapy’s 2022 Lifetime Achievement Award. Dr. Loeffler is a world leader with unparalleled experience in the treatment of brain and central nervous system (CNS) tumors and the use of stereotactic radiotherapy. His research, treatment methods and expertise have significantly contributed to the field of proton therapy.

Dr. Loeffler completed his Residency Program in Radiation Oncology at Harvard Medical School in Boston, Massachusetts. He joined the faculty of Joint Center for Radiation Therapy, Department of Radiation Therapy, Harvard Medical School as an instructor and progressed in the academic ranks to be promoted as the Andres Soriano Professor of Radiation Oncology, Harvard Medical School in 2000. He is devoted to educating and mentoring the next generation of Radiation Oncologists.

In addition to his commitment to education, he is dedicated to clinical research to advance the role of proton therapy in the management of patients with cancer. He became the Director of the Francis Burr Proton Therapy Center at Massachusetts General Hospital in 1996. During his tenure as the proton center director and then department chair of MGH, he has overseen the treatment of more than 10,000 children and adults with cancer. In his commitment to clinical research supporting the use of proton therapy, he has served as the principal investigator for NCI funded grant projects and has authored over 400 works on CNS radiotherapy and the importance of proton therapy.

Dr. Dennis Shrieve of University of Utah at Huntsman Cancer Institute states, “Dr. Jay Loeffler has devoted his professional life to the advancement of radiotherapy with the dual role of improving tumor control and limiting normal tissue toxicity. Under his leadership, proton therapy has become available to ever more patients worldwide. He is a passionate advocate for radiotherapy in general and proton therapy in particular”

The National Association for Proton Therapy will present the 2022 Lifetime Achievement Award to Dr. Loeffler during a special program on April 5, 2022, in St. Pete, Florida at the 10th Annual National Proton Conference.

Learn more at www.nationalprotonconference.com

###

The National Association for Proton Therapy (NAPT) is an independent nonprofit organization founded in 1990 to educate and increase awareness about the clinical benefits of proton therapy. Its members include 40 of the nation’s leading cancer centers many of whom are NCI-designated comprehensive cancer centers and NCCN members. The mission of NAPT is to work collaboratively to raise public awareness of the clinical benefits of proton therapy, ensure patients’ choice and access to affordable proton therapy, and encourage cooperative research and innovation to advance the appropriate and cost-effective utilization of proton therapy.

A full list of NAPT member centers can be found HERE along with recent supporting research.

  • Facebook
  • Twitter
  • Reddit
  • Pinterest
  • Google+
  • LinkedIn
  • E-Mail

JOIN US IN BOSTON!

NEWS BY TOPIC

Advocacy Events Member News NAPT Awards NAPT News News Patient Access Patient Stories Payment Stability Pediatric Cancer Press Releases Prior Authorization Proton Therapy In The News Research RO Model State Legislation VA Access

The National Association for Proton Therapy (NAPT) and its members support cancer research and treatment innovation and are committed to raising awareness about the value of proton therapy among policymakers, insurers, caregivers and patients to ensure that this advanced treatment modality is affordable and available in communities across the country.

  • Connected Community Log In
  • Privacy Policy
  • Terms of Use

LATEST NAPT NEWS

  • Insurance Delays and Denials Impede Vital Cancer Treatment
  • The Promise of Proton Therapy: A Ray of Hope for Esophageal Cancer Patients
  • Legal Battle for Life-Saving Cancer Treatment: How One Lawyer Took on Big Insurance to Expose a Broken System
  • Coach Ron Rivera awarded Cancer Support Community’s (CSC) Founders Award, Pledges to Pay It Forward
  • Just Released: 2023 NAPT Member Survey – Executive Summary

CONTACT US

The National Association for Proton Therapy 
PO Box 7801
McLean, VA 22106

202.919.4536

© 2023 National Association for Proton Therapy (NAPT)